Thomas Mcnerney & Partners Lp - Net Worth and Insider Trading
Thomas Mcnerney & Partners Lp Net Worth
The estimated net worth of Thomas Mcnerney & Partners Lp is at least $6 Million dollars as of 2024-05-11. Thomas Mcnerney & Partners Lp is the of Zogenix Inc and owns about 215,698 shares of Zogenix Inc (ZGNX) stock worth over $6 Million. Thomas Mcnerney & Partners Lp is also the 10% Owner of Clarus Therapeutics Holdings Inc and owns about 1,745,659 shares of Clarus Therapeutics Holdings Inc (CRXTQ) stock worth over $2,444. Details can be seen in Thomas Mcnerney & Partners Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas Mcnerney & Partners Lp has not made any transactions after 2022-04-20 and currently still holds the listed stock(s).
Transaction Summary of Thomas Mcnerney & Partners Lp
Thomas Mcnerney & Partners Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Mcnerney & Partners Lp owns 4 companies in total, including Ocera Therapeutics Inc (OCRX) , Zogenix Inc (ZGNX) , and Clarus Therapeutics Holdings Inc (CRXTQ) among others .
Click here to see the complete history of Thomas Mcnerney & Partners Lp’s form 4 insider trades.
Insider Ownership Summary of Thomas Mcnerney & Partners Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCRX | Ocera Therapeutics Inc | 2017-01-30 | 10 percent owner |
| ZGNX | Zogenix Inc | 2010-11-29 | other: See Footnote (10) |
| CRXTQ | Clarus Therapeutics Holdings Inc | 2022-04-20 | 10 percent owner |
 | | 2021-09-10 | 10 percent owner |
Thomas Mcnerney & Partners Lp Latest Holdings Summary
Thomas Mcnerney & Partners Lp currently owns a total of 2 stocks. Among these stocks, Thomas Mcnerney & Partners Lp owns 215,698 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $6 Million and a weighting of 99.96%. Thomas Mcnerney & Partners Lp also owns 1,745,659 shares of Clarus Therapeutics Holdings Inc (CRXTQ) as of April 20, 2022, with a value of $2,444 and a weighting of 0.04%.
Latest Holdings of Thomas Mcnerney & Partners Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZGNX | Zogenix Inc | 2010-11-29 | 215,698 | 26.68 | 5,754,823 |
| CRXTQ | Clarus Therapeutics Holdings Inc | 2022-04-20 | 1,745,659 | 0.00 | 2,444 |
Holding Weightings of Thomas Mcnerney & Partners Lp
Thomas Mcnerney & Partners Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Mcnerney & Partners Lp has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 22,153 shares on November 29, 2010, which cost Thomas Mcnerney & Partners Lp around $708,896.
According to the SEC Form 4 filings, Thomas Mcnerney & Partners Lp has made a total of 2 transactions in Clarus Therapeutics Holdings Inc (CRXTQ) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Clarus Therapeutics Holdings Inc is the sale of 3,752,912 shares on April 20, 2022, which brought Thomas Mcnerney & Partners Lp around $9 Million.
Insider Trading History of Thomas Mcnerney & Partners Lp
- 1
Thomas Mcnerney & Partners Lp Trading Performance
GuruFocus tracks the stock performance after each of Thomas Mcnerney & Partners Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Mcnerney & Partners Lp is 8.72%. GuruFocus also compares Thomas Mcnerney & Partners Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Mcnerney & Partners Lp within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas Mcnerney & Partners Lp's insider trading performs compared to the benchmark.
Performance of Thomas Mcnerney & Partners Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 42.56 | | | | | |
| Relative Return to S&P 500(%) | 36.5 | | | | | |
Thomas Mcnerney & Partners Lp Ownership Network
Thomas Mcnerney & Partners Lp Owned Company Details
What does Ocera Therapeutics Inc do?
Who are the key executives at Ocera Therapeutics Inc?
Thomas Mcnerney & Partners Lp is the 10 percent owner of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .
Ocera Therapeutics Inc (OCRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocera Therapeutics Inc Insider Transactions
Thomas Mcnerney & Partners Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Mcnerney & Partners Lp. You might contact Thomas Mcnerney & Partners Lp via mailing address: 45 S. 7th St., Suite 3060, Minneapolis Mn 55402.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
